關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗,我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示,便表示您已接受我們的網站使用條款。

搜尋結果Search Result

符合「Joint ventures」新聞搜尋結果, 共 251 篇 ,以下為 1 - 24 篇 訂閱此列表,掌握最新動態
GDIN Successfully Supports Establishment of 10 New Joint Ventures in 2024 Alone

GDIN CEO Jongkap Kim: "By matching technology needs with local markets, we create long-lasting joint ventures with multiple exit opportunities." SEOUL, South Korea, Dec. 24, 2024 /PRNewswire/ -- Global Digital Innovation Network (GDIN), led by CEO Jongkap Kim, proudly announced the major achievements of its 2024 Joint Venture Program. This program, which supports the establishment of joint ventures between South Korean companies and international partners, is designed to lower market entry barriers and create sustainable growth opportunities through local collaborations. 9 companies successfully established 10 joint ventures. Since the launch of the program in 2021, GDIN has supported the establishment of 44 joint ventures across various regions. This year alone, 10 joint ventures were successfully launched in 8 countries including the United States, Canada, Japan, India, Singapore, Vietnam, UAE, and Uganda. The Joint Venture Program was created to address a common challenge faced by early-stage tech companies: while they may have products and services that meet market demand, they often lack the resources and workforce to enter international markets. Through this program, GDIN helps companies increase their chances of success by facilitating strategic market entry via local partnerships. In addition to the 44 joint ventures established so far, 47 partnership agreements are in the pipeline for future joint ventures. The program's success is largely attributed to GDIN's extensive global network of partners, which includes government organizations, multinational corporations, and international agencies such as the World Bank, Central American Bank for Economic Integration (CABEI), Inter-American Development Bank (IDB), Investment Turkey etc. GDIN has organized multiple technology matching and investor relations events to introduce Korean companies and their innovative technologies to potential international partners. At the year-end performance report event, held on December 19, GDIN recognized companies that successfully established joint ventures. Changsoft I&I, a digital construction management system company, was highlighted for its success in establishing joint ventures in Japan and Vietnam. CFO Jongeun Park of Changsoft I&I shared, "We were facing stagnating revenue growth, and expanding into new markets was critical. With GDIN's support, we were able to establish joint ventures in Japan and Vietnam, allowing us to tailor our products to local market needs." Other companies that successfully established joint ventures in 2024 include Medicos Biotech, Bloomsbury Lab, Arbaim, Eucast, Pixelro, Hansol root one, Eco-Peace, and IESG. GDIN CEO Jongkap Kim commented, "Unlike simple joint investments or distribution networks, these technology-driven joint ventures are based on market demand, ensuring their long-term sustainability. If these joint ventures achieve success in the local markets and even go public, they could offer multiple exit opportunities, creating a strong growth model for all involved." About GDIN  Global Digital Innovation Network (formerly known as Born2Global Centre), registered under the Ministry of Science & ICT, is an independent foundation that promotes and fosters collaboration between next-level innovative companies from South Korea and the world. Since 2013, we have established over 160 international partnerships, supported over 3,000 tech companies, conducted over 20,000 consulting services, and helped companies raise $3.6 billion USD in investments.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 1008 加入收藏 :
KEPSA and MindHYVE.ai™ Sign Strategic Agreement to Launch National-Scale AGI Workforce, SME, and Innovation Initiatives Across Kenya

NAIROBI, Kenya and NEWPORT BEACH, Calif., July 15, 2025 /PRNewswire/ -- The Kenya Private Sector Alliance (KEPSA) has signed a landmark Memorandum of Understanding with MindHYVE.ai™, Inc., one of the world's fastest-growing developers of agentic artificial intelligence (AGI). Executed on June 5, 2025, the agreement establishes a national-scale collaboration to deploy domain-specialized AGI agents in service of Kenya's economic transformation, starting with workforce development, SME digital enablement, and innovation policy co-creation. At the core of this partnership are Arthur, Justine, and Eli, intelligent agents engineered for education, legal, and financial domains respectively. Each agent is powered by a dedicated Ava-Series large reasoning model: Arthur is powered by Ava-Education™ Justine by Ava-Legal™ Eli by Ava-Finance™ These agents, operating within platforms like ArthurAI™, are autonomous, adaptive, and capable of delivering real-time impact aligned with Kenya's national objectives. Strategic Programs and Initiatives 1. AGI Workforce Enablement Through ArthurAI™, KEPSA will upskill Kenya's workforce with multilingual learning, credentialing frameworks, and real-time analytics tailored to sector-specific needs. 2. SME Innovation Support A national AI Toolkit will empower small businesses with: Eli: Intelligent finance insights, credit simulation, and tax optimization Justine: Legal contract interpretation, compliance alerts, and literacy tools Arthur: Micro-course training and entrepreneurial education 3. Policy Co-Creation and Thought Leadership The partnership includes collaborative authorship of AGI policy readiness frameworks, public-private dialogue simulations using Justine, and deployment of Ava-Fusion™ to model policy impact scenarios. 4. National AI Innovation Council The parties will establish a cross-sector governance body to guide pilots, compliance, stakeholder feedback, and AGI scaling frameworks. 5. Flagship Launch Programs Ajira Digital AI Academy SME Digital Credit Lab Legal Literacy for Enterprises Executive Commentary "Our mission at MindHYVE is to engineer intelligence that doesn't just automate but elevates," said Bill Faruki, Founder and CEO of MindHYVE.ai™."This partnership with KEPSA shows what's possible when artificial general intelligence is built with purpose and deployed with trust. We are not simply supporting Kenya's digital transformation, we are co-architecting a future in which national intelligence infrastructure is adaptive, inclusive, and locally governed." Dr. Ehud Gachugu, Deputy CEO and Global Director of KEPSA, added:"With this partnership, Kenya takes a bold leap into applied AGI. We are not waiting to be shaped by the future; we are shaping it from within." Framework & Governance Term: Five years with renewable terms Oversight: Joint Steering Committee, quarterly reviews Compliance: Kenya's Data Protection Act (2019) IP & Licensing: Retained by original creator; joint assets governed cooperatively Public References: By mutual review and approval About KEPSA The Kenya Private Sector Alliance (KEPSA) is the country's principal private sector body, representing over one million businesses across sectors. It drives Kenya's economic policy agenda, digital transformation initiatives, and national development strategies through inclusive, enterprise-led solutions. About MindHYVE.ai™ MindHYVE.ai™ is a global leader in agentic AI systems, orchestrating intelligent agents built on large reasoning models tailored to specific domains. Through Ava-Fusion™ and the Ava-Series including Ava-Education™, Ava-Legal™, and Ava-Finance™. MindHYVE.ai is redefining how intelligence is deployed in law, healthcare, governance, education, and economic development. Media Contact MindHYVE.ai™ Marc OrtizEmail: marc.ortiz@mindhyve.aiPhone: +1 (949) 200-8668Website: www.mindhyve.ai

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 39 加入收藏 :
METABORA Partners with LINE NEXT to Distribute Web3 Games via Mini Dapp

METABORA becomes core partner in web3 game development for LINE NEXT's Dapp Portal BORA Utility to Expand through in-game payments and gas abstraction Implementation SEONGNAM, South Korea, July 14, 2025 /PRNewswire/ -- METABORA (Co-CEOs Lim Young-Jun and Choi Se-hoon), a global casual game developer and blockchain project operator, today announced a strategic partnership with LINE NEXT Inc. (CEO Youngsu Ko), LINE's venture dedicated to developing and expanding the global Web3 ecosystem. Through this partnership, METABORA will distribute Web3 games via the LINE Messenger–based Dapp Portal, expanding its reach in the Web3 gaming space. METABORA Partners with LINE NEXT to Distribute Web3 Games via Mini Dapp The Dapp Portal is a platform built on the KAIA ecosystem that offers Mini Dapps (decentralized applications) directly within the LINE Messenger app. Users can enjoy a variety of Mini Dapps—ranging from games to social features—without needing to install separate applications. Since its launch in January this year, the platform has garnered significant attention, surpassing 100 million cumulative users. Through this new partnership, METABORA and LINE NEXT will work closely to accelerate the growth of the Mini Dapp's gaming ecosystem. Leveraging its network of development partners and global experience in game development and publishing, METABORA will supply Web3 games to the Dapp Portal. LINE NEXT will expand accessibility to Web3 games and support marketing of these games through its platform. As part of the collaboration, METABORA will also expand the utility of its BORA token within the LINE Messenger–based Mini Dapp ecosystem. The company plans to implement a payment infrastructure that enables users to purchase in-game items currently planned for upcoming titles to be released under the BORA brand. Additionally, METABORA will apply Gas Abstraction technology, allowing users to make in-app purchases with BORA without needing KAIA tokens to cover gas fees. This feature is expected to be fully implemented in the second half of the year. By expanding the utility of the BORA token, METABORA aims to elevate its value beyond the confines of the BORA Chain, laying the groundwork for broader integration across the Web3 ecosystem. In addition, METABORA and LINE NEXT plan to continue their collaboration by researching and developing infrastructure to support the use of stable coins such as USDT, further enhancing the Web3 gaming experience within the LINE ecosystem centered on the Dapp Portal. Lim Youngjun, Co-CEO of METABORA, said, "We're pleased to partner with LINE NEXT, a company making remarkable strides in the global Web3 gaming market with its vast user base. Through our strong network of development partners, we will carefully select and bring high-quality games to the Dapp Portal, working together to create a leading example of Web3 gaming reaching a mainstream audience." Kim Woosuk, CSO at LINE NEXT, said, "Through this partnership with METABORA, we look forward to creating a major success case for Mini Dapp. Moving forward, we will continue working closely together across multiple fronts, including enabling USDT stablecoin support to improve game onboarding and the overall user payment environment." About METABORA METABORA is a casual game developer and the service operator of the blockchain platform BORA. The BORA ecosystem brings together partners across various industries—ranging from tokenomics and content to blockchain technology—driving innovation and collaboration across games, sports, and entertainment. Through the BORA Network, METABORA operates the BORA Portal, which offers GameFi-optimized services such as NFT trading, token conversion, and DeFi features. With BORA listed on major global cryptocurrency exchanges, METABORA continues to enhance accessibility and expand the usability of its content across the Web3 landscape.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 64 加入收藏 :
Bio Investments Group (BIG) and International Vaccine Institute (IVI) Forge Partnership to Accelerate Vaccine Self-Reliance in Africa and the Middle East

ZUG, Switzerland and SEOUL, July 11, 2025 /PRNewswire/ -- The Bio Investments Group AG (BIG), a leading global healthcare-technology transfer platform, and the International Vaccine Institute (IVI), an international organization dedicated to advancing vaccine discovery, development, and delivery, today announced the signing of a Memorandum of Understanding (MoU) to establish a strategic collaboration aimed at accelerating local vaccine manufacturing, clinical evidence generation, and capacity building across Africa and the Middle East. This partnership underscores a shared vision to enhance global health security by fostering vaccine self-reliance in emerging markets, aligning BIG's execution and investment capabilities with IVI's technical guidance and global vaccine research, development, and regulatory expertise. "This MoU marks a pivotal moment in our mission to localize life-science capabilities where they are needed most," said Sam Machour, CEO & Chairman of the Bio Investments Group. "By partnering with IVI, a globally respected institution, we are combining our investment and pharmaceutical technical capabilities in cutting-edge infrastructure and technology transfer with their deep vaccines scientific and public health expertise. Our joint efforts will accelerate the pace to self-sufficiency, will not only bring high-quality vaccines closer to African populations but also empower local economies through sustainable manufacturing and job creation." Key Areas of Cooperation under the MoU include: Local Manufacturing & Technology Transfer: IVI will provide technical expertise and regulatory support to facilitate WHO prequalification for locally manufactured products, while BIG will lead infrastructure development and technology transfer execution, ensuring efficient, high-quality local vaccine production in Africa. Clinical Development & Data Generation: IVI will coordinate clinical trials, effectiveness studies, and safety research in Africa to generate the necessary evidence base for vaccine introduction and public-sector adoption, with BIG supporting industrial engagement and market access strategies. Capacity Building & Vaccine Self-Reliance: IVI will offer training programs and technical assistance to develop local expertise, supporting public-private partnerships for vaccine self-reliance. BIG will invest in physical infrastructure, such as Centers of Excellence, and collaborate on vaccine security strategies, aiming to build a sustainable local workforce and establish regional leadership in vaccine manufacturing. This collaboration is expected to significantly contribute to Africa's public health agenda by fostering a robust and resilient vaccine ecosystem, reducing reliance on imports, and strengthening regional preparedness for future health challenges. About Bio Investments Group (BIG): Bio Investments Group AG is a Swiss-registered healthcare-industrial platform dedicated to accelerating the localization of life-science capabilities, including vaccines, biologics, diagnostics, and cold-chain services, across emerging markets. With operational hubs in Zug, Hong Kong, Dubai, and Riyadh, BIG focuses on transferring technology, building infrastructure, and fostering local expertise to achieve genuine manufacturing sovereignty. About International Vaccine Institute (IVI): The International Vaccine Institute (IVI) is an international organization dedicated to advancing vaccine discovery, development, and delivery—especially for vulnerable communities. Through research, partnerships, and innovation, IVI enhances global health, strengthens pandemic preparedness, and ensures equitable access to life-saving vaccines worldwide. Media Contact: www.bioinvgroup.com

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 584 加入收藏 :
Bio Investments Group (BIG) and International Vaccine Institute (IVI) Forge Partnership to Accelerate Vaccine Self-Reliance in Africa and the Middle East

ZUG, Switzerland and SEOUL, July 11, 2025 /PRNewswire/ -- The Bio Investments Group AG (BIG), a leading global healthcare-technology transfer platform, and the International Vaccine Institute (IVI), an international organization dedicated to advancing vaccine discovery, development, and delivery, today announced the signing of a Memorandum of Understanding (MoU) to establish a strategic collaboration aimed at accelerating local vaccine manufacturing, clinical evidence generation, and capacity building across Africa and the Middle East.     This partnership underscores a shared vision to enhance global health security by fostering vaccine self-reliance in emerging markets, aligning BIG's execution and investment capabilities with IVI's technical guidance and global vaccine research, development, and regulatory expertise. "This MoU marks a pivotal moment in our mission to localize life-science capabilities where they are needed most," said Sam Machour, CEO & Chairman of the Bio Investments Group. "By partnering with IVI, a globally respected institution, we are combining our investment and pharmaceutical technical capabilities in cutting-edge infrastructure and technology transfer with their deep vaccines scientific and public health expertise. Our joint efforts will accelerate the pace to self-sufficiency, will not only bring high-quality vaccines closer to African populations but also empower local economies through sustainable manufacturing and job creation." Key Areas of Cooperation under the MoU include: Local Manufacturing & Technology Transfer: IVI will provide technical expertise and regulatory support to facilitate WHO prequalification for locally manufactured products, while BIG will lead infrastructure development and technology transfer execution, ensuring efficient, high-quality local vaccine production in Africa. Clinical Development & Data Generation: IVI will coordinate clinical trials, effectiveness studies, and safety research in Africa to generate the necessary evidence base for vaccine introduction and public-sector adoption, with BIG supporting industrial engagement and market access strategies. Capacity Building & Vaccine Self-Reliance: IVI will offer training programs and technical assistance to develop local expertise, supporting public-private partnerships for vaccine self-reliance. BIG will invest in physical infrastructure, such as Centers of Excellence, and collaborate on vaccine security strategies, aiming to build a sustainable local workforce and establish regional leadership in vaccine manufacturing. This collaboration is expected to significantly contribute to Africa's public health agenda by fostering a robust and resilient vaccine ecosystem, reducing reliance on imports, and strengthening regional preparedness for future health challenges. About Bio Investments Group (BIG): Bio Investments Group AG is a Swiss-registered healthcare-industrial platform dedicated to accelerating the localization of life-science capabilities, including vaccines, biologics, diagnostics, and cold-chain services, across emerging markets. With operational hubs in Zug, Hong Kong, Dubai, and Riyadh, BIG focuses on transferring technology, building infrastructure, and fostering local expertise to achieve genuine manufacturing sovereignty. About International Vaccine Institute (IVI): The International Vaccine Institute (IVI) is an international organization dedicated to advancing vaccine discovery, development, and delivery—especially for vulnerable communities. Through research, partnerships, and innovation, IVI enhances global health, strengthens pandemic preparedness, and ensures equitable access to life-saving vaccines worldwide. Logo: https://mma.prnasia.com/media2/2729494/Bio_Investments_Group_Logo.jpg?p=medium600 Media Contact: www.bioinvgroup.com

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 625 加入收藏 :
BDx Data Centers Launches Southeast Asia's First Hybrid Quantum AI Testbed in Singapore

BDx signs a memorandum of understanding (MoU) with Anyon Technologies to deploy Southeast Asia's first hybrid quantum computer at its flagship SIN1 data center in Paya Lebar, Singapore. Regional 'AI Testbed' aims to support government agencies, enterprises, and start-ups in advancing AI-quantum innovation Initiative aligns with Singapore's Green 2030 and Smart Nation strategies by integrating next-gen computing with sustainable infrastructure. SINGAPORE, July 10, 2025 /PRNewswire/ -- BDx Data Centers ("BDx"), a leading carrier-neutral data center platform in Asia, has launched Southeast Asia's first hybrid quantum AI testbed in collaboration with Anyon Technologies, a global leader in large-scale quantum computing systems. The MoU signing today formalized the collaboration, paving the way for the deployment of the region's first hybrid quantum computer at BDx's flagship SIN1 facility in Paya Lebar, Singapore. This groundbreaking initiative will enable startups, enterprises, and government agencies to explore quantum-enhanced AI applications. Designed to support Singapore's Green 2030 and Smart Nation objectives, the testbed integrates Anyon's quantum computing system with SIN1's cutting-edge infrastructure. "Staying ahead of the curve has always been part of our DNA at BDx," said Mayank Srivastava, CEO of BDx. "Our journey, from deploying the most advanced NVIDIA GPUs across the region to now integrating quantum computing into our data center, reflects our commitment to not just keeping pace with innovation but shaping its future. Together, we are building an open platform that creates new opportunities to unlock the transformative potential of quantum computing." "A modern computer today is essentially a whole data center. Deploying a state-of-the-art hybrid quantum computing system at BDx's SIN1 facility marks a transformative step in modern computing infrastructure," said Dr Jie (Roger) Luo, President and CEO of Anyon Technologies. "By integrating QPUs (Quantum Processing Units) with CPUs (Central Processing Units) and GPUs (Graphics Processing Units), we're enabling breakthroughs in quantum algorithms and applications. This lowers adoption barriers for enterprise customers, like financial institutions in Singapore, to onboard talent and create real, differentiating business value." Accelerating AI and Quantum Innovation in Singapore and Beyond BDx's SIN1 facility will serve as a cross-regional AI Hub and Innovation Center, dedicated to supporting high-growth AI startups and government-led innovation initiatives. To accelerate AI adoption across Southeast Asia, BDx is providing dedicated access to its AI-ready infrastructure, enabling companies and startups to experiment with transformative technologies. By building an open and scalable platform, BDx aims to drive real-world impact across AI, research, and enterprise applications. "Operators in Asia have a critical role in building the ecosystem needed to accelerate AI adoption within the region. Singapore is a global innovation hub and an ideal environment for our AI testbed - we're providing developers with the tools to experiment, prototype, and scale their ideas efficiently," added Srivastava. SIN1 also sets a sustainability benchmark, with a 20% boost in energy efficiency, achieved through advanced cooling and smart automation. It features Singapore's first AI-powered digital twin, optimizing energy and performance in real time, and is compliant with Singapore's Green Data Center Standards. Looking forward, BDx and Anyon plan to expand this hybrid quantum model across key markets in Asia, including Indonesia, Hong Kong SAR, and Taiwan region, creating a region-wide network of quantum-enabled data centers.  

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 131 加入收藏 :
2025 年 7 月 16 日 (星期三) 農曆六月廿二日
首 頁 我的收藏 搜 尋 新聞發佈